近日，一家名为Bioptimus的AI生物科学基础模型初创公司宣布，在成立仅数月后，成功完成了3500万美元的种子轮融资。这一轮融资由法国生命科学风投公司Sofinnova Partners和公共银行Bpifrance Large Ventures共同领投，其他参与投资的包括法国风险投资公司Frst和Cathay Innovation、美国投资者Headline、Owkin以及亿万富翁企业家Xavier Niel。
Bioptimus的愿景是利用人工智能技术为生物技术领域构建一个庞大的语言模型。这一轮融资的完成，不仅标志着Bioptimus在生物科学领域的创新潜力得到了认可，也预示着人工智能在生物科学领域的应用前景广阔。
随着人工智能技术的不断进步，其在生物科学领域的应用越来越广泛。Bioptimus的融资成功，不仅为其自身的发展注入了强大的动力，也为整个行业带来了新的希望。未来，Bioptimus有望通过其开发的大型语言模型，为生物技术研究提供更加高效和精准的解决方案，推动生物科学领域的创新和发展。
英文标题：AI Biotech Startup Bioptimus Secures $35M in Seed Funding
英文关键词：Artificial Intelligence, Biotechnology, Startup
英文新闻内容：
A French artificial intelligence (AI) biotech startup named Bioptimus has secured a significant seed funding round of $35 million, just months after its establishment. The round was led by Sofinnova Partners, a French life science venture capital firm, and Bpifrance Large Ventures, a public bank, with additional investments from French venture capital firm Frst and Cathay Innovation, as well as American investors Headline, Owkin, and billionaire entrepreneur Xavier Niel.
Bioptimus aims to build a large language model for the biotech industry using AI technology. The successful completion of this funding round not only validates the potential of Bioptimus in the biological sciences field but also highlights the promising applications of AI in biotechnology.
As AI technology advances, its applications in biological sciences are becoming increasingly diverse. The funding success of Bioptimus not only injects strong momentum into its own growth but also brings new hope to the industry. In the future, Bioptimus is expected to provide more efficient and precise solutions for biotech research through its developed large language model, propelling innovation and development in the field of biological sciences.
【来源】https://sifted.eu/articles/bioptimus-owkin-35m-seed
Views: 2